These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2482548)

  • 21. Catalysis of thrombin inhibition provides an index for estimating the antithrombotic potential of glycosaminoglycans in rabbits.
    Fernandez FA; Buchanan MR; Hirsh J; Fenton JW; Ofosu FA
    Thromb Haemost; 1987 Jun; 57(3):286-93. PubMed ID: 3116701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standard assays underestimate the concentration of heparin in neonatal plasma.
    Schmidt B; Mitchell L; Ofosu F; Andrew M
    J Lab Clin Med; 1988 Nov; 112(5):641-3. PubMed ID: 3183496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of heparin cofactor II in the modulation of hemostasis.
    Salem HH; Thompson EA
    Dev Biol Stand; 1987; 67():67-72. PubMed ID: 3301469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the interaction of IL-8 with human plasma alpha 2-macroglobulin: evidence for the presence of IL-8 complexed to alpha 2-macroglobulin in lung fluids of patients with adult respiratory distress syndrome.
    Kurdowska A; Carr FK; Stevens MD; Baughman RP; Martin TR
    J Immunol; 1997 Feb; 158(4):1930-40. PubMed ID: 9029135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interactions between antithrombin III, thrombin and surface immobilized heparin.
    van Delden CJ; Engbers GH; Feijen J
    J Biomater Sci Polym Ed; 1996; 7(11):989-1004. PubMed ID: 8858487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic properties of heparin in a neonatal piglet model of thrombin-induced thrombosis.
    Schmidt B; Buchanan MR; Ofosu F; Brooker L; Hirsh J; Andrew M
    Thromb Haemost; 1988 Oct; 60(2):289-92. PubMed ID: 3217922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The alpha 2 macroglobulin/thrombin interaction in the presence of hydroxylamine.
    Lambin P; Pochon F; Fine JM; Steinbuch M
    Thromb Res; 1983 Oct; 32(2):123-32. PubMed ID: 6197765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of functional and inactivated alpha 2-macroglobulin in sepsis.
    Abbink JJ; Nuijens JH; Eerenberg AJ; Huijbregts CC; Strack van Schijndel RJ; Thijs LG; Hack CE
    Thromb Haemost; 1991 Jan; 65(1):32-9. PubMed ID: 1708920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K
    Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wall.
    Pasche B; Swedenborg J; Frebelius S; Olsson P
    Thromb Res; 1991 Jun; 62(5):409-19. PubMed ID: 1896960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reaction of alpha 2-macroglobulin with plasmin increases binding of transforming growth factors-beta 1 and beta 2.
    LaMarre J; Wollenberg GK; Gonias SL; Hayes MA
    Biochim Biophys Acta; 1991 Jan; 1091(2):197-204. PubMed ID: 1704799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulation of human factor XIIa by plasma proteinase inhibitors.
    Pixley RA; Schapira M; Colman RW
    J Biol Chem; 1985 Feb; 260(3):1723-9. PubMed ID: 2578463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: importance of heparin cofactor II.
    Buchanan MR; Liao P; Smith LJ; Ofosu FA
    Thromb Res; 1994 Jun; 74(5):463-75. PubMed ID: 8085247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of transforming growth factor-beta-1 with alpha-2-macroglobulin from normal and inflamed equine joints.
    Coté N; Trout DR; Hayes MA
    Can J Vet Res; 1998 Oct; 62(4):279-86. PubMed ID: 9798094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Machovich R; Borsodi A; Blaskó G; Orakzai SA
    Biochem J; 1977 Nov; 167(2):393-8. PubMed ID: 74248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
    Tanaka KA; Szlam F; Vinten-Johansen J; Cardin AD; Levy JH
    Thromb Haemost; 2005 Oct; 94(4):808-13. PubMed ID: 16270635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.